Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Rhythm Pharmaceuticals buy The Goldman Sachs Group, Inc.

Rhythm Pharmaceuticals
Start price
€23.20
02.03.23 / 50%
Target price
€42.45
02.03.24
Performance (%)
69.83%
End price
€39.40
03.03.24
Summary
This prediction ended on 03.03.24 with a price of €39.40. The BUY prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals saw massive gains of 69.83%. The_Goldman_Sachs_Gr has a follow-up prediction for Rhythm Pharmaceuticals where he still thinks Rhythm Pharmaceuticals is a Buy. The_Goldman_Sachs_Gr has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Rhythm Pharmaceuticals 4.895% 4.895% 41.509% 309.836%
iShares Core DAX® 3,59 % 6,43 % 15,38 % 52,31 %
iShares Nasdaq 100 5,81 % 6,38 % 41,46 % 91,77 %
iShares Nikkei 225® 4,08 % 9,31 % 48,95 % 65,86 %
iShares S&P 500 4,14 % 4,94 % 31,59 % 65,33 %

Comments by The_Goldman_Sachs_Gr for this prediction

In the thread Rhythm Pharmaceuticals diskutieren
Prediction Buy
Perf. (%) 69.83%
Target price 42.449
Change
Ends at 02.03.24

Rhythm Pharmaceuticals, Inc. (NASDAQ: RYTM) had its price target raised by analysts at The Goldman Sachs Group, Inc. from $40.00 to $45.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat

The Goldman Sachs Group, Inc. 
0
Report Share
02.03.23
In the thread Trading Rhythm Pharmaceuticals
Prediction Buy
Perf. (%) 69.83%
Target price 42.449
Change
Ends at 02.03.24

Die von The_Goldman_Sachs_Gr gewählte maximale Laufzeit wurde überschritten

The Goldman Sachs Group, Inc. 
0
Report Share
03.03.24

Current prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€80.50
10.07.25
€82.61
10.07.26
-6.21%
17.04.26

The Goldman Sachs Group, Inc. 
10.07.25 50%

Stopped prediction by The_Goldman_Sachs_Gr for Rhythm Pharmaceuticals

buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€99.00
12.12.25
-
12.12.26
-23.74%
17.04.26

The Goldman Sachs Group, Inc. 
12.12.25 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€93.00
17.10.25
-
17.10.26
-18.82%
17.04.26

The Goldman Sachs Group, Inc. 
17.10.25 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€81.00
24.09.25
€116.94
24.09.26
-7.41%
17.04.26

The Goldman Sachs Group, Inc. 
24.09.25 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€55.00
05.12.24
€62.44
05.12.25
60.00%
06.12.25

The Goldman Sachs Group, Inc. 
05.12.24 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€40.80
25.01.24
€47.88
25.01.25
34.80%
26.01.25

The Goldman Sachs Group, Inc. 
25.01.24 50%
buy
Rhythm Pharmaceuticals

Start price
Target price
Perf. (%)
€35.40
07.12.23
€38.96
07.12.24
51.13%
08.12.24

The Goldman Sachs Group, Inc. 
07.12.23 50%